|
Market Closed -
NYSE
16:01:06 2026-11-06 EST
|
5-day change | 1st Jan Change | ||
| 165.40 USD | -1.02% |
|
+2.37% | +15.41% |
| 11-05 | Wendy's rejects Trian-led $1.4 billion buyout offer, adopts 'poison pill' plan | RE |
| 11-05 | Kimberly-Clark Third-Quarter Earnings Top Street Views Despite Macro Volatility | MT |
Company Valuation: Procter & Gamble Company
Data adjusted to current consolidation scope
| Fiscal Period: June | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 344,995 | 357,647 | 389,234 | 373,532 | 341,466 | 383,361 | - | - |
| Change | - | 3.67% | 8.83% | -4.03% | -8.58% | 12.27% | - | - |
| Enterprise Value (EV) 1 | 369,274 | 384,008 | 412,212 | 398,484 | 365,662 | 409,031 | 407,687 | 405,505 |
| Change | - | 3.99% | 7.34% | -3.33% | -8.24% | 11.86% | -0.33% | -0.54% |
| P/E | 24.7x | 25.7x | 27.4x | 24.5x | 22.2x | 24.2x | 22.5x | 21.4x |
| PBR | 7.35x | 7.66x | 8.06x | 7.48x | 6.54x | 6.97x | 6.66x | 6.3x |
| PEG | - | 16.59x | 13.47x | 3.01x | 13.14x | 7.56x | 3x | 4.28x |
| Capitalization / Revenue | 4.3x | 4.36x | 4.63x | 4.43x | 3.92x | 4.27x | 4.14x | 4x |
| EV / Revenue | 4.61x | 4.68x | 4.91x | 4.73x | 4.2x | 4.56x | 4.4x | 4.23x |
| EV / EBITDA | 17.9x | 18.4x | 18x | 17.1x | 15.5x | 16.7x | 15.8x | 15.1x |
| EV / EBIT | 20.7x | 21.2x | 20.6x | 19.5x | 17.8x | 19.3x | 18.4x | 17.5x |
| EV / FCF | 27.2x | 27.9x | 24.9x | 27.3x | 24.1x | 26.5x | 24.3x | 22.5x |
| FCF Yield | 3.67% | 3.59% | 4.01% | 3.67% | 4.14% | 3.77% | 4.12% | 4.45% |
| Dividend per Share 2 | 3.523 | 3.681 | 3.829 | 4.076 | 4.259 | 4.403 | 4.603 | 4.823 |
| Rate of return | 2.45% | 2.43% | 2.32% | 2.56% | 2.9% | 2.66% | 2.78% | 2.92% |
| EPS 2 | 5.81 | 5.9 | 6.02 | 6.51 | 6.62 | 6.832 | 7.345 | 7.712 |
| Distribution rate | 60.6% | 62.4% | 63.6% | 62.6% | 64.3% | 64.4% | 62.7% | 62.5% |
| Net sales 1 | 80,187 | 82,006 | 84,039 | 84,284 | 87,032 | 89,785 | 92,601 | 95,944 |
| EBITDA 1 | 20,620 | 20,848 | 22,884 | 23,303 | 23,657 | 24,524 | 25,775 | 26,886 |
| EBIT 1 | 17,813 | 18,134 | 19,988 | 20,456 | 20,497 | 21,158 | 22,208 | 23,198 |
| Net income 1 | 14,742 | 14,653 | 14,879 | 15,974 | 16,046 | 16,350 | 17,504 | 18,202 |
| Net Debt 1 | 24,279 | 26,361 | 22,978 | 24,952 | 24,196 | 25,670 | 24,326 | 22,143 |
| Reference price 2 | 143.79 | 151.74 | 164.92 | 159.32 | 146.64 | 165.40 | 165.40 | 165.40 |
| Nbr of stocks (in thousands) | 2,399,297 | 2,356,969 | 2,360,135 | 2,344,542 | 2,328,599 | 2,317,783 | - | - |
| Announcement Date | 7/29/22 | 7/28/23 | 7/30/24 | 7/29/25 | 7/29/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 24.46x | 4.6x | 16.84x | 2.63% | 387B | |
| 34.78x | 5.26x | 21.87x | 1.69% | 272B | |
| 19.69x | 2.96x | 13.09x | 3.19% | 146B | |
| 27.13x | 3.97x | 16.58x | 2.15% | 78.45B | |
| 18.83x | 4.4x | 20.41x | 4.67% | 67.78B | |
| 62.59x | 8.86x | 34.21x | 0.25% | 55.83B | |
| 41.22x | 6.54x | 28.77x | 2.29% | 49.28B | |
| 35.14x | 2.7x | 14.46x | 1.34% | 39B | |
| 25.17x | 1.84x | 11.75x | 2.01% | 22.29B | |
| 22.81x | 1.5x | 9.86x | 1.16% | 21.01B | |
| Average | 31.18x | 4.26x | 18.78x | 2.14% | 113.91B | |
| Weighted average by Cap. | 29.11x | 4.61x | 18.81x | 2.35% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- PG Stock
- Valuation Procter & Gamble Company
Select your edition
All financial news and data tailored to specific country editions
